Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Isabel Navarro Arce"'
Autor:
Eduardo de Teresa, Fernando Cabrera Bueno, Nasiba Abdeselam-Mohamed, Isabel Navarro‐Arce, Juan José Gómez Doblas, José Manuel García Pinilla, Amalio Ruiz Salas, Manuel Jiménez Navarro, Alberto Barrera Cordero, Javier Alzueta, Luis Morcillo-Hidalgo
Publikováno v:
Journal of Cardiovascular Electrophysiology. 29:1523-1529
INTRODUCTION Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited cardiomyopathy characterized by ventricular arrhythmias and heart failure. The variable phenotype suggesting that determined environmental factors may hav
Autor:
Amalio Ruiz-Salas, Isabel Navarro-Arce, Carmen Medina-Palomo, Alberto Barrera-Cordero, Manuel Jiménez-Navarro, Eloy Rueda-Calle, José Manuel García-Pinilla, Fernando Cabrera-Bueno, Luis Morcillo-Hidalgo, Juan José Gómez-Doblas, Javier Alzueta
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC/D) is an inherited cardiomyopathy characterized by ventricular arrhythmias and heart failure. The aim of our study was to analyze the impact of the ICD indication in the prognosis of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2cc8f47ab812918269ec1dca918d4ae
https://doi.org/10.21203/rs.2.16672/v1
https://doi.org/10.21203/rs.2.16672/v1
Autor:
Manuel Galán-Ortega, Jose Cruz-Mañas, José María Melero-Tejedor, Manuel Rubio-Navarro, Lourdes Garrido-Sánchez, Alicia Ramirez-Fernandez, Concepción Santiago Fernandez, Daniel Ariza-Villanueva, Juan Alcaide Torres, Ana Florez-Vela, Isabel Navarro Arce, María Isabel Moreno-Cortés, Jose L Guerrero-Orriach
Publikováno v:
Therapeutics and Clinical Risk Management
José Luis Guerrero-Orriach,1 Daniel Ariza-Villanueva,1 Ana Florez-Vela,1 Lourdes Garrido-Sánchez,2,3 María Isabel Moreno-Cortés,1 Manuel Galán-Ortega,1 Alicia Ramírez-Fernández,1 Juan Alcaide Torres,3 Concepción Santiago Fernandez,3 Isabel Na
Autor:
Jose Cruz Mañas, Manuel Rubio Navarro, Manuel Galan Ortega, Isabel Navarro Arce, Jose Luis Guerrero Orriach, M. Ramirez Aliaga
Publikováno v:
Current pharmaceutical design. 19(22)
Recently, many studies have shown a decrease in myocardial damage in patients undergoing coronary artery bypass surgery where the anesthetic agent used was sevoflurane compared with propofol. The basis for this protective effect of the myocardium occ
Autor:
Pablo Iglesias, Jose Luis Guerrero Orriach, Manuel Rubio Navarro, Isabel Navarro Arce, Jose Cruz Mañas, Manuel Galan Ortega
Publikováno v:
Revista Española de Cardiología. 66:999-1000